Monoclonal Antibody 216
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monoclonal Antibody 216, covering 2012-07-03 to 2012-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia [Phase 1]